Amicus Therapeutics Announces Participation at the 2022 AANEM Annual Meeting
PHILADELPHIA, Sept. 21, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), today announced three poster presentations highlighting its development program for Pompe disease will be included at the 2022 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, being held September 21-24, 2022 in Nashville, TN and virtually.
Related news for (FOLD)
- Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
- Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
- Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
- Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
- 24/7 Market News Snapshot 17 October, 2024 – Amicus Therapeutics, Inc (NASDAQ:FOLD)